+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology - Thematic Research

  • PDF Icon

    Report

  • 24 Pages
  • September 2018
  • Region: Global
  • GlobalData
  • ID: 4661770
Biotechnology - Thematic Research

Summary

At its core, biotechnology is harnessing biological and molecular systems to develop products and processes.It is divided into three areas: agricultural biotechnology, which includes development of genetically modified crops; industrial biotechnology, which includes production of chemicals, paper and textiles; and medical biotechnology which includes the themes covered in this report such as biosimilars and the microbiome.

The report "Biotechnology - Thematic Research", focuses on the most important and fastest growing areas of biotechnology which are its application to health and medicine. The reports coverage includes medical biotechnology, although it does provide an overview of the players in the whole industry. It splits the main trends impacting the biotech theme into seven categories: macroeconomic trends, technology trends, immuno-oncology trends, pharmacogenomics trends, biosimilar trends, gene therapy trends, and microbiome trends.

Since the human genome was first sequenced in 2003, the cost of sequencing has come down dramatically and our knowledge of what the sequence means has increased significantly.This has helped drive advances and investment in biotechnology fields such as pharmacogenomics, which uses information in a person’s genes to inform how they will react to different drugs and therapeutics, as well as gene therapy and immuno-oncology. This report provides a summary of the key trends impacting the biotechnology industry and its significance to health and medicine.

The thematic report also predicts that companies which make the most effective use of the modern data tools are going to be successful while, in the long run, big pharma could be threatened by patent expiration and rising competition unless they invest.

Scope
  • This report focuses on the biotechnology sector and its most important and fastest growing areas.

  • It identifies some of the leading players across the three big segments within the biotechnology industry, including industrial biotechnology, agricultural biotechnology, and medical biotechnology.

  • It outlines the scientific technology behind the five main themes in medical biotechnology and why they are important today.

  • It highlights the main trends in the biotechnology industry over the next 12 to 24 months.


Reasons to buy
  • Since the human genome was first sequenced in 2003, the cost of sequencing has come down dramatically and our knowledge of what the sequence means has increased significantly.

  • This has helped drive advances and investment in biotechnology fields such as pharmacogenomics, which uses information in a person’s genes to inform how they will react to different drugs and therapeutics, as well as gene therapy and immuno-oncology. This report provides a summary of the key trends impacting the biotechnology industry and its significance to health and medicine.

Table of Contents

PLAYERS

TECHNOLOGY BRIEFING
  • Immuno-oncology

  • Pharmacogenomics

  • Biosimilars

  • Gene therapy

  • Microbiome


TRENDS
  • Macroeconomic trends

  • Technology trends

  • Immuno-oncology trends

  • Pharmacogenomics trends

  • Biosimilar trends

  • Gene therapy trends

  • Microbiome trends


GLOSSARY

APPENDIX: “THEMATIC” RESEARCH METHODOLOGY

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis
  • Gilead Sciences
  • Bristol-Myers Squibb
  • Merck
  • Celgene
  • Illumina
  • 23andMe
  • BGI Shenzhen
  • Quest Diagnostics
  • Viviphi
  • Sandoz
  • Amgen
  • Accord Healthcare
  • Hospira
  • Spark Therapeutics
  • GlaxoSmithKline
  • Quethera
  • AOBiome
  • Enterome Bioscience
  • Rebiotix
  • 4D Pharma